Ulrich Schopfer is Head, Chemical Biology & Therapeutics at the Novartis Institutes for BioMedical Research (NIBR) in Basel/Switzerland. The department applies chemical biology, data science and enabling technologies to discover novel targets, to prototype new drug modalities and to contribute drug candidates to the Novartis pipeline. Previously he held different leadership roles in early drug discovery after starting his career at Novartis as medicinal chemist and project team leader in Neuroscience. Throughout his career, Ulrich has been intrigued by the relationship between molecular structure and biological function. Obtaining a PhD in organic chemistry for work in conformational design of bioactive molecules with R.W. Hoffmann in Marburg/Germany, he pursued postdoctoral work with R. Noyori at Nagoya University/Japan followed by a visiting scholar year working on artificial zinc finger transcription factors with C.F Barbas at The Scripps Research Institute/La Jolla.